Recap: Aptose Biosciences Q4 Earnings
Recap: Aptose Biosciences Q4 Earnings
Aptose Biosciences (NASDAQ:APTO) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:02 PM.
Aptose Biosciences（纳斯达克股票代码：APTO）于2024年3月26日星期二下午4点02分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Aptose Biosciences beat estimated earnings by 9.0%, reporting an EPS of $-1.44 versus an estimate of $-1.59.
Aptose Biosciences的收益比预期高出9.0％，每股收益为-1.44美元，而估计为-1.59美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.29 which was followed by a 24.0% drop in the share price the next day.
上个季度，该公司的每股收益高出0.29美元，随后第二天股价下跌了24.0％。
To track all earnings releases for Aptose Biosciences visit their earnings calendar here.
要追踪Aptose Biosciences的所有财报，请在此处访问其财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。